Free Trial

BioLife Solutions (BLFS) News Today

$21.48
-0.27 (-1.24%)
(As of 05/31/2024 ET)
BioLife Solutions, Inc. (NASDAQ:BLFS) CFO Sells $12,501.72 in Stock
BioLife Solutions, Inc. (NASDAQ:BLFS) Short Interest Up 12.9% in May
BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) saw a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 4,020,000 shares, a growth of 12.9% from the April 30th total of 3,560,000 shares. Based on an average daily volume of 423,600 shares, the short-interest ratio is currently 9.5 days.
BioLife Solutions, Inc. (NASDAQ:BLFS) Stake Raised by Millrace Asset Group Inc.
Millrace Asset Group Inc. lifted its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 116.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 105,643 shares of the medical equipment provider
BioLife Solutions, Inc. (NASDAQ:BLFS) Short Interest Update
BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) saw a large growth in short interest in April. As of April 30th, there was short interest totalling 3,560,000 shares, a growth of 14.8% from the April 15th total of 3,100,000 shares. Based on an average trading volume of 390,800 shares, the days-to-cover ratio is currently 9.1 days.
BioLife Solutions (NASDAQ:BLFS) Shares Gap Up to $19.54
BioLife Solutions (NASDAQ:BLFS) Shares Gap Up to $19.54
BioLife Solutions, Inc. (NASDAQ:BLFS) Given Average Rating of "Buy" by Analysts
Shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) have been assigned a consensus recommendation of "Buy" from the five research firms that are presently covering the company, Marketbeat.com reports. Five research analysts have rated the stock with a buy rating. The average 12-month
BioLife Solutions (NASDAQ:BLFS) Upgraded by Benchmark to Buy
Benchmark raised shares of BioLife Solutions from a "neutral" rating to a "buy" rating and set a $25.00 price target for the company in a research note on Monday.
BioLife Solutions, Inc. (NASDAQ:BLFS) is Roubaix Capital LLC's 9th Largest Position
Roubaix Capital LLC grew its position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 90.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 280,337 shares of the medical e
BioLife Solutions (NASDAQ:BLFS) Rating Increased to Sell at StockNews.com
StockNews.com upgraded BioLife Solutions to a "sell" rating in a research note on Friday.
BioLife Solutions (NASDAQ:BLFS) Issues Earnings Results
BioLife Solutions (NASDAQ:BLFS - Get Free Report) issued its earnings results on Thursday. The medical equipment provider reported ($0.19) EPS for the quarter, beating the consensus estimate of ($0.25) by $0.06. The company had revenue of $31.73 million during the quarter, compared to the consensus estimate of $29.30 million. BioLife Solutions had a negative return on equity of 13.36% and a negative net margin of 46.37%. During the same period last year, the business posted ($0.27) EPS.
BioLife Solutions (NASDAQ:BLFS) Trading 15.7% Higher on Better-Than-Expected Earnings
BioLife Solutions (NASDAQ:BLFS) Trading 15.7% Higher After Earnings Beat
BioLife Solutions, Inc. (NASDAQ:BLFS) Shares Sold by Geneva Capital Management LLC
Geneva Capital Management LLC reduced its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 42.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 874,485 shares of the medical equipm
BioLife Solutions Inc (BLFS)
Jennison Associates LLC Lowers Stock Position in BioLife Solutions, Inc. (NASDAQ:BLFS)
Jennison Associates LLC cut its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 90.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 39,978 shares of the medical equipment provider's stock after selling
BioLife Solutions (NASDAQ:BLFS) Trading 4.2% Higher
BioLife Solutions (NASDAQ:BLFS) Stock Price Up 4.2%
BioLife Solutions, Inc. (NASDAQ:BLFS) CFO Sells $14,636.36 in Stock
BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) CFO Troy Wichterman sold 956 shares of the firm's stock in a transaction on Thursday, April 18th. The stock was sold at an average price of $15.31, for a total transaction of $14,636.36. Following the completion of the sale, the chief financial officer now owns 126,658 shares of the company's stock, valued at approximately $1,939,133.98. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.
BioLife Solutions (NASDAQ:BLFS) Shares Up 5.4%
BioLife Solutions (NASDAQ:BLFS) Trading 5.4% Higher
BioLife Solutions, Inc. (NASDAQ:BLFS) CMO Sells $156,700.00 in Stock
BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) CMO Todd Berard sold 10,000 shares of the company's stock in a transaction that occurred on Monday, April 15th. The stock was sold at an average price of $15.67, for a total value of $156,700.00. Following the sale, the chief marketing officer now directly owns 129,644 shares in the company, valued at $2,031,521.48. The sale was disclosed in a filing with the SEC, which is available through this link.
BioLife Solutions, Inc. (NASDAQ:BLFS) Sees Significant Growth in Short Interest
BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) saw a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 3,200,000 shares, a growth of 5.6% from the March 15th total of 3,030,000 shares. Based on an average daily volume of 412,500 shares, the short-interest ratio is currently 7.8 days.
BioLife Solutions (NASDAQ:BLFS) Trading 4.9% Higher
BioLife Solutions (NASDAQ:BLFS) Trading 4.9% Higher
BioLife Solutions (NASDAQ:BLFS) Shares Gap Up to $17.32
BioLife Solutions (NASDAQ:BLFS) Shares Gap Up to $17.32
Jefferies Financial Group Begins Coverage on BioLife Solutions (NASDAQ:BLFS)
Jefferies Financial Group assumed coverage on shares of BioLife Solutions in a report on Thursday. They issued a "buy" rating and a $22.00 price target on the stock.
BioLife Solutions, Inc. (NASDAQ:BLFS) Insider Sells $70,600.00 in Stock
BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) insider Sarah Aebersold sold 4,000 shares of the stock in a transaction on Monday, April 1st. The shares were sold at an average price of $17.65, for a total transaction of $70,600.00. Following the completion of the sale, the insider now directly owns 65,843 shares of the company's stock, valued at $1,162,128.95. The sale was disclosed in a filing with the SEC, which is available through the SEC website.
Get BioLife Solutions News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter.

Trump’s Gift Could Unleash $51 Billion in New Wealth (Ad)

In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.

You just have to make this simple move before July 30, 2024.

BLFS Media Mentions By Week

BLFS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BLFS
News Sentiment

0.46

0.76

Average
Medical
News Sentiment

BLFS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BLFS Articles
This Week

12

3

BLFS Articles
Average Week

Get BioLife Solutions News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:BLFS) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners